Ajay Samkaria/LinkedIn
May 22, 2026, 13:36
Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
Ajay Samkaria, Product and Application Manager India at Diagast, shared a post on LinkedIn:
“Crossmatch protects the present transfusion.
Antibody screening protects the patient’s future.
A compatible crossmatch does not always mean complete transfusion safety.
Some clinically significant antibodies may still go undetected unless proper antibody screening is performed.
That’s why modern transfusion medicine is shifting from: ‘minimum compatibility’ to ‘future transfusion safety.’
Think Beyond Crossmatch.
Think Antibody Screening.
Think Patient Safety.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation